Platelet Transfusion (Blood Platelet Transfusions)
1052
relevant articles (64 outcomes,
70 trials/studies)
found for this Therapy
Description:
The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
Also Known As:
Blood Platelet Transfusions; Platelet Transfusion, Blood; Platelet Transfusions; Platelet Transfusions, Blood; Transfusion, Blood Platelet; Transfusion, Platelet; Transfusions, Blood Platelet; Transfusions, Platelet; Blood Platelet Transfusion
Relationship Network
Therapy Context: Research Results
Experts
| 1. | Brand, Anneke:
2 articles
(10/2007 - 09/2004)
|
| 2. | Vogelsang, Georgia B:
2 articles
(09/2007 - 05/2007)
|
| 3. | Nevo, Shoshan:
2 articles
(09/2007 - 05/2007)
|
| 4. | Hartley, Eric:
2 articles
(09/2007 - 05/2007)
|
| 5. | Fuller, Alice K:
2 articles
(09/2007 - 05/2007)
|
| 6. | Borinsky, Mark E:
2 articles
(09/2007 - 05/2007)
|
| 7. | O'Donovan, Donough J:
2 articles
(03/2006 - 03/2005)
|
| 8. | Fernandes, Caraciolo J:
2 articles
(03/2006 - 03/2005)
|
| 9. | Vassiliou, I:
1 article
(06/2008)
|
| 10. | Paraskeva, Anteia:
1 article
(06/2008)
|
Related Diseases
| 1. | Hemorrhage
|
| 2. | Thrombocytopenia (Thrombopenia)
|
| 3. | Infection
05/01/1986
- " With regard to the indication of BMT, the following factors were selected as significantly favorable: young age, in remission, no infection, complete HLA-matched marrow donor, no previous radiation treatment of the brain or lung, fractionated TBI, low dose rate, platelet transfusion from anti-CMV antibody-negative donor" 07/01/2003
- " Platelet transfusion studies demonstrate that platelet-derived CD154 alone is sufficient to induce isotype switching and augment T lymphocyte function during viral infection, leading to enhanced protection against viral rechallenge" 08/01/2008
- " Four patients experienced severe iatrogenic infections, and 11 patients required platelet transfusions" 08/01/2008
- " Among 2,774 propensity matched-pairs, platelet transfusion was associated with similar or reduced morbidity, platelets versus no platelets: cardiac 2.42% vs 1.77%, p = 0.09; pulmonary 8.94% vs 9.88%, p = 0.23; renal 1.33% vs 1.48%, p = 0.65; neurologic 2.27% vs 3.21%, p = 0.033; serious infection 4.15% vs 5.34%, p = 0.037; and composite outcome 15.0% vs 17.2%, p = 0.024" 08/04/2007
- " However, platelet transfusion can transmit infections and trigger serious immune reactions and they can be rendered ineffective by alloimmunisation"
Get all the results and reference details, order at left...
|
| 4. | Thrombasthenia (Glanzmann Thrombasthenia)
|
| 5. | Leukemia
|
| 200 Diseases
and
1052
more articles analyzed in the Research Interface, order at left...
|
Related Drugs and Biologics
Related Therapies and Procedures